Unfortunately, the never ending saga of Nilotinib continues on. There had been several stories floating around about problems between MJFF and the Georgetown research team as the reason that GU couldn't obtain funding for a larger phase 2 study. I didn't think the problems were as bad as that reported in this article. Nevertheless, the GU trial is still not fully funded and will continue to be delayed. The MJFF trials are probably a year away from beginning, if not more. Meanwhile, the PD community waits, twiddling their fingers with frustration, as to why it takes so long to proceed with a trial for a well known drug that has been approved and on the market for years. I am willing to bet that I could get 100 volunteers in one week, who would sign waivers and begin taking the drug immediately. It's very hard to maintain patience when one has a progressive degenerative disease. It's much easier if you just fund or do the research, your life is not on the line.

Parkinson's disease study caught in feud involving Fox Foundation